1,000 filings
8-K
SEEL
Seelos Therapeutics, Inc.
3 Sep 24
Entry into a Material Definitive Agreement
9:00am
EFFECT
SEEL
Seelos Therapeutics, Inc.
26 Aug 24
Notice of effectiveness
12:15am
ARS
2023 FY
SEEL
Seelos Therapeutics, Inc.
20 Aug 24
Annual report to shareholders
4:03pm
DEF 14A
SEEL
Seelos Therapeutics, Inc.
Definitive proxy
20 Aug 24
4:01pm
S-3
SEEL
Seelos Therapeutics, Inc.
Shelf registration
16 Aug 24
4:02pm
8-K
mvlwfw vn
8 Aug 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:06pm
D
t06hszsg
30 Jul 24
$1.15 mm in options / securities to be acquired, 3 investors
4:23pm
8-K
a0g3p
26 Jul 24
Other Events
4:01pm
8-K
ricalgkuyz
16 Jul 24
Entry into a Material Definitive Agreement
4:05pm
8-K
q2ux65ho6 m95gmved
12 Jul 24
Entry into a Material Definitive Agreement
9:15am
EFFECT
rnpj1bq 8fy2
26 Jun 24
Notice of effectiveness
12:15am
424B3
6wldpbd
25 Jun 24
Prospectus supplement
4:23pm
8-K
pekes18iocw jl
5 Jun 24
Entry into a Material Definitive Agreement
4:05pm
D
9cslv71
31 May 24
$2.04 mm in options / securities to be acquired, 2 investors
4:30pm
8-K
fc6ojyknj6kbonb pwm
21 May 24
Entry into a Material Definitive Agreement
4:01pm
424B5
250qxxq
20 May 24
Prospectus supplement for primary offering
4:16pm
8-K
l3nky b8w7q
16 May 24
Material Modifications to Rights of Security Holders
9:00am